Day 1
3 September 2021
12:00 to 12:15 (BST)
Opening ceremony
Chair: Punith Kempegowda, Organising Chair, EYES 2021 (UK)
Welcome from Eva Coopmans, Co-Chair, EYES (Netherlands)
Welcome from Ms Helen Gregson (Chief Executive Officer, European Society of Endocrinology)
12:15 to 13:05 (BST)
Panel Discussion on Academic Careers
Chair: Prof Davide Calebiro (Birmingham, UK)
Dr Gabriela Da Silva Xavier (Birmingham, UK)
Dr Rowan Hardy (Birmingham, UK)
Prof David Hodson (Birmingham, UK)
Dr Vicki Smith (Birmingham, UK)
Panel Q&A - Academic careers overview and discussion: encouraging the next generation of early career researchers and endocrinologists
Comfort Break 13:05–13:10
13:10 to 13:30 (BST)
Career insights from reproductive and adrenal endocrinology
Chair: Dr Alessandro Prete (UK)
Dr Michael O’Reilly (Dublin, Ireland)
13:30 to 15:00 (BST)
Adrenal oral presentations
Chairs: Dr Alessandro Prete (UK), Dr Antoan Stefan Sojat (Serbia)
OR1: Should the approach to non-classic congenital adrenal hyperplasia (NCAH) be changed? - a real-life validation of NCAH diagnostic process (Bartosz Domagała, Poland)
OR2: Evaluation of urinary free cortisol and late night salivary cortisol as diagnostic tools for Cushing’s Syndrome (Roberto Novizio, Italy)
OR3: Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral massive adrenal hyperplasia (Ru Zhang, Germany)
OR4: Characterization of transcriptional and miRNA based dysregulations in Cushing’s syndrome (Sharmilee Vetrivel, Germany)
OR5: Impact of adrenalectomy on cardiovascular features in patients with adrenal incidentalomas and possible autonomous cortisol secretion: results from ITACA study (Marianna Minnetti, Italy)
OR6: Adverse events associated to mitotane treatment in patients with adrenocortical carcinoma (Barbara Altieri, Germany)
Comfort Break 15:00–15:10
15:10 to 16:40 (BST)
Pituitary and Neuroendocrinology oral presentations
Chairs: Dr Manuel D Gahete (Spain), Dr Walter Vena (Italy)
OR1: Pituitary adenoma consistency is associated with postoperative hormonal deficits: a retrospective study on 50 patients undergoing transsphenoidal adenomectomy (Dario De Alcubierre, Italy)
OR2: A novel molecular subclassification may predict somatostatin analogs response in corticotropinomas (Alejandro Ibáñez-Costa, Spain)
OR3: Hormonal adjustment to metabolic derangement in adult Growth Hormone Deficiency: evaluation of Ghrelin and LEAP-2 serum levels (Edoardo Vergani, Italy)
OR4: Indexes of chronic low-grade inflammation in different models of insulin-resistance: evaluation of lipocalin-2 in metabolic syndrome, partial and total growth hormone deficiency (Carmine Bruno, Italy)
OR5: Digital Transformation of a Hyponatraemia Toolkit: Impact on Clinical Practice (Christina O'Dowd, UK)
OR6: Altered splicing machinery as a source of biomarkers in lung neuroendocrine neoplasms (Ricardo Blázquez-Encinas, Spain)
16:40 to 17:40 (BST)